Search Results - "Hackett CS"

Focused ultrasound as a therapeutic adjunct in pancreatic cancer: from thermal and mechanical effects to immune modulation.

Authors: Lee, Jae Young Lafon, Cyril Mouratidis, Petros et al.

Source: Ultrasonography. May2026, Vol. 45 Issue 3, p195-204. 10p.

CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit.

Authors: Yi F Cohen T Zimmerman N et al.

Source: Nature cancer [Nat Cancer] 2025 Oct; Vol. 6 (10), pp. 1638-1655. Date of Electronic Publication: 2025 Jul 22.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Adoptive T‐cell therapies in the clinic.

Authors: Shaha, Suyog Lourenco, Leah Zhao, Zongmin et al.

Source: Bioengineering & Translational Medicine. May2026, Vol. 11 Issue 3, p1-32. 32p.

Real-world treatment patterns, healthcare resource use, and costs among patients with diffuse large B-cell lymphoma: a retrospective analysis of US claims data.

Authors: Garg, Mahek Satija, Ambika Song, Yan et al.

Source: Leukemia & Lymphoma. Aug2025, Vol. 66 Issue 8, p1447-1456. 10p.

Cell-based immunotherapy in oesophageal cancer.

Authors: Lahouty, Masoud Soleymanzadeh, Amirhossein Kazemi, Sama et al.

Source: Journal of Drug Targeting. Aug2025, Vol. 33 Issue 7, p1114-1124. 11p.

A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma.

Authors: DeStefano, Vincent M Wada, Masayuki Pinz, Kevin G et al.

Source: Clinical & Translational Medicine. Jul2024, Vol. 14 Issue 7, p1-6. 6p.

Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti‐tumour activity.

Authors: Wang, Yao Li, Jianhuan Wang, Zhiqian et al.

Source: Cell Proliferation. Nov2024, Vol. 57 Issue 11, p1-14. 14p.

Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma.

Authors: Wang, Hanyu Wang, Gaoxiang Li, Tongjuan et al.

Source: Journal of Translational Medicine. 6/5/2025, Vol. 23 Issue 1, p1-13. 13p.

The Therapeutic Potential of CAR γδ T Cells: From Cancer to Autoimmune Disease.

Authors: Lee, Chanu Che, Suhyun Baek, Jea-Hyun

Source: Biocell. 2026, Vol. 50 Issue 2, p1-26. 26p.

NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors.

Authors: Teng, Xia Li, Shance Zhang, Chaoting et al.

Source: Experimental Hematology & Oncology. 4/3/2025, Vol. 14 Issue 1, p1-17. 17p.

Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer.

Authors: Liu, Nan Wei, Wenwen Ren, Kexing et al.

Source: Medcomm: Oncology. Mar2025, Vol. 4 Issue 1, p1-17. 17p.

Circular RNAs in cancer: Its biogenesis, functions, relationships with cancer progression, applications in immunotherapy and biomarker potentials.

Authors: Gao Y Xu L Sun R et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 31; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Bispecific CAR T and CAR NK cells in dual-threat immunotherapy: opportunities and challenges.

Authors: Shahin Baher A Khalid A Ganjalikhani Hakemi A et al.

Source: Molecular biology reports [Mol Biol Rep] 2026 Jun 19; Vol. 53 (1). Date of Electronic Publication: 2026 Jun 19.

Publication Type: Journal Article; Review

Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

Overcoming T cell exhaustion and senescence in CAR T cell therapy for solid tumors.

Authors: Pérez-Criado I Figols M Moya-Sevilla A et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 May 07. Date of Electronic Publication: 2026 May 07.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor.

Authors: Liao, Ziyan Jiang, Jie Wu, Wei et al.

Source: National Science Review. Apr2024, Vol. 11 Issue 4, p1-10. 10p.

Chimeric antigen receptor (CAR) T-cell therapy in dermatology: A narrative review.

Authors: Gowda, Shreya K Gupta, Sonali Verma, Kaushal K et al.

Source: Indian Journal of Dermatology, Venereology & Leprology. Jan/Feb2026, Vol. 92 Issue 1, p1-8. 8p.

Optimizing the safety of chimeric antigen receptor T cell therapy — current strategies and future direction.

Authors: Szymkiewicz, Anna E. Walczak, Filip M. Trzpiot, Sylwia et al.

Source: Nowotwory. 2026, Vol. 76 Issue 1, p45-53. 9p.

Engineering the tumor microenvironment: oncolytic NDV to facilitate CAR-T cell therapy.

Authors: Wang, Mei Jiang, Ke Aicher, Alexandra et al.

Source: Journal of Translational Medicine. 11/19/2025, Vol. 23 Issue 1, p1-15. 15p.

Nanoparticle-based strategy in CAR-T cell immunotherapy: challenges, implications, and perspectives.

Authors: Shang, Dong Zhou, Zhaokai Shi, Run et al.

Source: Molecular Cancer. 11/4/2025, Vol. 24 Issue 1, p1-38. 38p.

FEN1 inhibitor SC13 promotes CAR‐T cells infiltration into solid tumours through cGAS–STING signalling pathway.

Authors: Dong, Yunfei Wang, Yuanyuan Yin, Xuechen et al.

Source: Immunology. Nov2023, Vol. 170 Issue 3, p388-400. 13p.